Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 722.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,520.00 | |
50 mg | In stock | $ 1,980.00 |
Description | AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD). |
Synonyms | GSK 842470, GSK-842470, AWD12-281, AWD-12-281, GW 842470 |
Molecular Weight | 458.27 |
Formula | C22H14Cl2FN3O3 |
CAS No. | 257892-33-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AWD 12-281 257892-33-4 Metabolism PDE GSK 842470 GSK-842470 GSK842470 AWD12-281 AWD 12281 AWD 12 281 AWD-12-281 GW 842470 inhibitor inhibit